Effect of silencing CITED1 gene to regulate PI3K/AKT pathway on the biological function of PTC cells and its

Wanzhi Chen1, Jichun Yu2, Rong Xie3

  • 1Department of Thyroid Surgery, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, 330006, China. Chenwanzhi111@163.com.

Insights

Silencing the CITED1 gene inhibits papillary thyroid carcinoma (PTC) cell progression by regulating the PI3K/AKT pathway. This leads to reduced cell proliferation and invasion, alongside increased apoptosis in PTC cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Papillary thyroid carcinoma (PTC) is a common endocrine malignancy.
  • The PI3K/AKT signaling pathway plays a crucial role in cell growth, survival, and invasion in various cancers, including PTC.
  • The role of the CITED1 gene in PTC progression and its interaction with the PI3K/AKT pathway requires further elucidation.

Purpose of the Study:

  • To investigate the effect of CITED1 gene silencing on the biological functions of human PTC cells.
  • To determine the mechanism by which CITED1 regulates the PI3K/AKT pathway in PTC.
  • To assess the impact of CITED1 silencing on cell proliferation, apoptosis, and invasion in PTC.

Main Methods:

  • Human PTC SW1736 cells were utilized and divided into control, siCITED1, LY294002 (PI3K/AKT inhibitor), and combined treatment groups.
  • CITED1 gene silencing was achieved via siCITED1 plasmid transfection.
  • Cell proliferation, apoptosis, invasion, and PI3K/AKT pathway protein/mRNA expression levels were analyzed.

Main Results:

  • Silencing CITED1 significantly decreased PTC cell proliferation and invasion while increasing apoptosis.
  • Inhibition of the PI3K/AKT pathway with LY294002 also reduced proliferation and invasion and increased apoptosis.
  • CITED1 silencing led to decreased PI3K and AKT protein expression, suggesting pathway regulation.

Conclusions:

  • CITED1 gene silencing effectively inhibits the progression of papillary thyroid carcinoma cells.
  • The inhibitory effect is mediated through the downregulation of the PI3K/AKT signaling pathway.
  • Targeting CITED1 represents a potential therapeutic strategy for PTC.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.6K
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
8.9K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.5K